Bionano Genomics, Inc. (BNGO)
NASDAQ: BNGO · Real-Time Price · USD
1.190
+0.020 (1.71%)
Jun 9, 2026, 1:15 PM EDT - Market open
Bionano Genomics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 3.43 | 2.99 | 9.17 | 17.95 | 5.09 | 24.57 |
Short-Term Investments | 10.98 | 16.28 | 0.3 | 48.82 | 108.1 | 226.04 |
Cash & Short-Term Investments | 14.41 | 19.27 | 9.48 | 66.77 | 113.19 | 250.61 |
Cash Growth | -20.99% | 103.37% | -85.81% | -41.01% | -54.84% | 551.80% |
Accounts Receivable | 4.13 | 5.2 | 4.75 | 9.32 | 7.02 | 4.93 |
Inventory | 5.31 | 5.45 | 11.12 | 22.89 | 29.76 | 12.39 |
Other Current Assets | 15.13 | 15.47 | 14.14 | 41.14 | 7.33 | 4.48 |
Total Current Assets | 38.98 | 45.39 | 39.49 | 140.12 | 157.3 | 272.41 |
Net Property, Plant & Equipment | 20.15 | 21.16 | 24.32 | 32.48 | 28.96 | 37.46 |
Other Intangible Assets | 3.01 | 4.35 | 9.71 | 33.97 | 41.14 | 56.16 |
Goodwill | - | - | - | - | 77.29 | 0.75 |
Other Long-Term Assets | 2.68 | 2.69 | 3.15 | 7.83 | 2.81 | 11.07 |
Total Assets | 64.8 | 73.58 | 76.67 | 214.4 | 307.5 | 377.1 |
Accounts Payable | 5.06 | 5.59 | 6.96 | 10.38 | 12.53 | 10.77 |
Accrued Expenses | 4 | 5.46 | 5.64 | 8.09 | 10.55 | 8.62 |
Short-Term Debt | 10.15 | 9.98 | 20.36 | 69.8 | - | - |
Current Portion of Leases | 0.89 | 0.95 | 3.25 | 2.44 | 2.55 | 1.77 |
Unearned Revenue | 1.13 | 0.97 | 1.13 | 0.78 | 0.87 | 0.68 |
Other Current Liabilities | - | - | - | 8.53 | 9.38 | - |
Total Current Liabilities | 21.23 | 22.94 | 37.34 | 100.03 | 35.88 | 21.84 |
Long-Term Leases | 5.97 | 5.97 | 3.68 | 7.18 | 9.12 | 8.93 |
Other Long-Term Liabilities | 0.14 | 0.25 | 0.27 | 11.04 | 13.1 | 9.21 |
Total Long-Term Liabilities | 6.11 | 6.22 | 3.95 | 18.22 | 22.22 | 18.14 |
Total Liabilities | 27.34 | 29.16 | 41.3 | 118.25 | 58.1 | 39.98 |
Common Stock | 0 | 0 | - | - | 0 | 0.03 |
Additional Paid-in Capital | 765.37 | 764.03 | 728.57 | 677.34 | 599.23 | 553.75 |
Accumulated Other Comprehensive Income | 0.01 | 0.02 | 0.03 | 0.02 | -1.12 | -0.54 |
Retained Earnings | -727.92 | -719.62 | -693.23 | -581.21 | -348.72 | -216.12 |
Shareholders' Equity | 37.46 | 44.42 | 35.38 | 96.16 | 249.4 | 337.12 |
Total Liabilities & Equity | 64.8 | 73.58 | 76.67 | 214.4 | 307.5 | 377.1 |
Total Debt | 17.01 | 16.89 | 27.3 | 79.41 | 11.67 | 10.7 |
Net Cash (Debt) | -2.61 | 2.38 | -17.82 | -12.64 | 101.52 | 239.92 |
Net Cash Growth | - | - | - | - | -57.69% | 984.42% |
Net Cash Per Share | -0.00 | 0.44 | -14.02 | -22.22 | 210.61 | 520.08 |
Book Value | 37.46 | 44.42 | 35.38 | 96.16 | 249.4 | 337.12 |
Book Value Per Share | 0.02 | 8.16 | 27.83 | 168.99 | 517.40 | 730.79 |
Tangible Book Value | 34.46 | 40.08 | 25.67 | 62.18 | 130.97 | 280.21 |
Tangible Book Value Per Share | 0.02 | 7.36 | 20.20 | 109.28 | 271.70 | 607.43 |